INSP250117C105000
- 0.00
- 0.000.00%
Inspire Medical Systems Newsroom
Hold Rating on Inspire Medical Systems Amid FDA Approval of Tirzepatide for OSA
The Price Is Right For Inspire Medical Systems, Inc. (NYSE:INSP)
Inspire Medical Systems' (NYSE:INSP) Returns On Capital Are Heading Higher
Express News | Resmed Shares Down 4% and Inspire Medical Systems Shares Fall 2.7% in Early Trading
Express News | Shares of Sleep Apnea Device Makers Resmed and Inspire Medical Systems Fall After US FDA Approves Eli Lilly's Weight-Loss Drug to Treat Sleep Apnea
Coupa Announces Inspire May 12-15 and Inspire World Tour Roadshow
Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Maintains Target Price $198
Inspire Medical Systems: Balancing Growth Prospects and Market Challenges – A Hold Rating by Larry Biegelsen
Presidio Medical Announces Appointment of Richard J. Buchholz to Join Its Board of Directors
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Express News | Inspire Medical Systems Inc : Leerink Partners Cuts Target Price to $193 From $197
Sector Update: Health Care Stocks Advance Late Afternoon
Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade
BofA Securities Upgrades Inspire Medical Systems(INSP.US) to Buy Rating, Raises Target Price to $255
Returns At Inspire Medical Systems (NYSE:INSP) Are On The Way Up
Inspire Medical Systems Maintains Strong Market Position Amidst LIVN's Aura6000 Uncertainties
Lake Street Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $270
Inspire Medical Accelerates $75M Stock Repurchase as Part of $150M Buyback Plan
Express News | Inspire Medical Systems, Inc. Announces $75 Million Accelerated Share Repurchase Program
A Quick Look at Today's Ratings for Inspire Medical Systems(INSP.US), With a Forecast Between $200 to $270